Your shopping cart is empty!
CLSI NBS07-Ed1 (R2022) PDF
Product Code:
Availability:
Availability:
product
In Stock
In Stock
$99.00
$180.00
IN TAX $99.00
IN TAX $99.00
Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid alpha-Glucosidase Activity Assays, 1st Edition, NBS07Ed1E
| Published by | Publication Date | Number of Pages |
| CLSI | 03/01/2017 | 70 |
CLSI NBS07-Ed1 (R2022) – Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid alpha-Glucosidase Activity Assays, 1st Edition, NBS07Ed1E
This report discusses the detection of Pompe disease (PD) by population-based newborn screening using dried blood spot specimens to measure acid α-glucosidase enzyme activity. Classic infantile-onset PD is a lethal disorder that is not evident at birth, and therapy effectiveness is improved by presymptomatic detection.
Reviews (0)